WTB RSS
02-15-2012, 06:19 PM
Regeneron Pharmaceuticals Inc. 's ( REGN ) fourth quarter 2011 net loss (excluding special items but including stock-based compensation) of 54 cents per share was narrower thanhttp://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/0/di (http://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/0/da)
http://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/1/di (http://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/GSxSs-lF78Q
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/GSxSs-lF78Q/regenerons-loss-widens-eylea-grows-analyst-blog.aspx)
http://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/1/di (http://feedads.g.doubleclick.net/~a/Gg6rkdswrIkkBO1I6F-ZFLvXGJk/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/GSxSs-lF78Q
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/GSxSs-lF78Q/regenerons-loss-widens-eylea-grows-analyst-blog.aspx)